Article Details

DALVANCE® (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin ...

Retrieved on: 2021-07-24 07:52:30

Tags for this article:

Click the tags to see associated articles and topics

DALVANCE® (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin .... View article details on hiswai:

Excerpt

Exercise caution in patients with known hypersensitivity to glycopeptides due to the possibility of cross-sensitivity. If an allergic reaction occurs, treatment ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up